Basic Information
LncRNA/CircRNA Name | H19 |
Synonyms | NA |
Region | GRCh38_11:1995176-2001470 |
Ensemble | ENSG00000130600 |
Refseq | NR_002196 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | steroid hormones | |
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | uterine leiomyoma |
ICD-0-3 | C57.4 |
Methods | qRT-PCR , in vitro knockdown etc. |
Sample | fibroid and myometrial tissues ,cell lines(ht-UtLM cells ,primary UtLM-1 and UtLM-2 cells) |
Expression Pattern | up-regulated |
Function Description | Expression levels of GASL1 in prostate tissues and sera from patients with PC and from healthy subjects were detected.GASL1 was significantly downregulated in the tissue and serum of patients with PC compared to those of healthy subjects. In addition, GASL1 was used to distinguish patients with PC from healthy controls, and low expression levels of GASL1 were associated with short survival time. Expression levels of GASL1 were significantly associated with tumor size. GASL1 overexpression inhibited PC cell growth. Overexpression of GASL1 upregulated Bcl-2 expression and downregulated GLUT-1 expression. |
Pubmed ID | 31089260 |
Year | 2019 |
Title | H19 lncRNA Identified as a Master Regulator of Genes That Drive Uterine Leiomyomas |
External Links
Links for H19 | GenBank HGNC NONCODE |
Links for uterine leiomyoma | OMIM COSMIC |